A comparison of acellular dermal matrices (ADM) efficacy and complication profile in women undergoing implant-based breast reconstruction: a systematic review and network meta-analysis.

BMC Cancer · 2024 · PMC11686910 · PMID 39741248

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

While DermACELL had a decrease in risk of 58% in comparing to AlloDerm RTU (RR = 0.42, 95%CI: 0.13, 1.33), however, this also failed to reach statistical significance (Fig. 2 B).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.